Effects of cadmium on platelet thromboxane and vascular prostacyclin production
- 1 August 1982
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 65 (1) , 185-188
- https://doi.org/10.1016/0041-008x(82)90378-7
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Hemostasis, Thrombosis, and Thromboembolic Disorders: The Role of Arachidonic Acid Metabolites in Platelet-Vessel Wall InteractionsMedical Clinics of North America, 1981
- Cadmium-induced platelet hypersensitivity to aggregating agentsPharmacological Research Communications, 1979
- Inhibition of prostacyclin-like material formation by cadmiumToxicology and Applied Pharmacology, 1979
- Blood Cadmium Level and Hypertension in HumansClinical Toxicology, 1978
- Increased vascular response to adrenergic stimulation in rats exposed to cadmiumJournal of Toxicology and Environmental Health, 1978
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- BLOOD-CADMIUM LEVELS IN NORMOTENSIVE AND UNTREATED HYPERTENSIVE HUMANSThe Lancet, 1976
- Cadmium and vascular reactivity in the ratToxicology and Applied Pharmacology, 1975
- Vascular Reactivity of Rats Altered by Cadmium and a Zinc ChelateArchives of environmental health, 1970
- The relationship of cadmium in the air to cardiovascular disease death ratesJAMA, 1966